Association of folate-pathway gene polymorphisms with the risk of prostate cancer: A population-based nested case-control study, systematic review, and meta-analysis

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 9, 2009, Pages 2528-2539

  Collin, Simon M ^a   Metcalfe, Chris ^a   Zuccolo, Luisa ^a   Lewis, Sarah J ^a   Chen, Lina ^a   Cox, Angela ^b   Davis, Michael ^a   Lane, J Athene ^a   Donovan, Jenny ^a   Smith, George Davey ^a   Neal, David E ^c   Hamdy, Freddie C ^e   Gudmundsson, Julius ^f   Sulem, Patrick ^f   Rafnar, Thorunn ^f   Benediktsdottir, Kristrun R ^f   Eeles, Rosalind A ^g,h   Guy, Michelle ^g   Kote Jarai, Zsofia ^g   Morrison, Jonathan ^d   Al Olama, Ali Amin ^d   Stefansson, Kari ^f   Easton, Douglas F ^d   Martin, Richard M ^a   O'Brien, Lynne ^g,h   Wilkinson, Rosemary ^g,h   Hall, Amanda ^g,h   Sawyer, Emma ^g,h   more..

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^g INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^h INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLATE HYDROLASE 1; FOLIC ACID; GAMMA GLUTAMYL HYDROLASE; GLYCINE HYDROXYMETHYLTRANSFERASE; METHIONINE SYNTHASE; METHIONINE SYNTHASE REDUCTASE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; REDUCED FOLATE CARRIER; SERINE HYDROXYMETHYLTRANSFERASE 1; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CANCER RISK; CLINICAL TRIAL; DIET SUPPLEMENTATION; FOLATE METABOLISM; GENE FREQUENCY; GENE INTERACTION; GENOTYPE; HOMOZYGOSITY; HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; CASE-CONTROL STUDIES; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; GLUTAMATE CARBOXYPEPTIDASE II; GLYCINE HYDROXYMETHYLTRANSFERASE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NADP); METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 70349331579     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0223     Document Type: Article

References (64)

1. Choi SW, Friso S. Interaction between folate and methylene- tetrahydrofolate reductase gene in cancer. In: Choi SW, Friso S, editors. Nutrient-Gene Interactions in Cancer. CRC Press; 2006. p. 57-74.
2. Dong LM, Potter JD, White E, et al. Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA 2008;299:2423-2436 (Pubitemid 351749241)
3. Ulrich CM. Genetic variability in folate-mediated one-carbon metabolism and cancer risk. In: Choi SW, Friso S, editors. Nutrient-Gene Interactions in Cancer. CRC Press; 2006. p. 75-91.
4. Choi SW, Mason JB. Folate and carcinogenesis: an integrated scheme. J Nutr 2000;130:129-132
5. Dobosy JR, Roberts JL, Fu VX, Jarrard DF. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia. J Urol 2007;177:822-831
6. Murphy TM, Perry AS, Lawler M. The emergence of DNA methylation as a key modulator of aberrant cell death in prostate cancer. Endocr Relat Cancer 2008;15:11-25.
7. Kim YI. Role of folate in colon cancer development and progression. J Nutr 2003;133:3731-9S.
8. Vlajinac HD, Marinkovic JM, Ilic MD, Kocev NI. Diet and prostate cancer: a case-control study. Eur J Cancer 1997;33:101-107 (Pubitemid 27099576)
9. Weinstein SJ, Hartman TJ, Stolzenberg-Solomon R, et al. Null association between prostate cancer and serum folate, vitamin B(6), vitamin B(12), and homocysteine. Cancer Epidemiol Biomarkers Prev 2003;12:1271-1272
10. Hultdin J, Van GB, Bergh A, Hallmans G, Stattin P. Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: a prospective study. Int J Cancer 2005;113:819-824 (Pubitemid 40101265)
11. Pelucchi C, Galeone C, Talamini R, et al. Dietary folate and risk of prostate cancer in Italy. Cancer Epidemiol Biomarkers Prev 2005;14:944-948 (Pubitemid 40478561)
12. Stevens VL, Rodriguez C, Pavluck AL, et al. Folate nutrition and prostate cancer incidence in a large cohort of US men. Am J Epidemiol 2006;163:989-996 (Pubitemid 43987590)
13. Weinstein SJ, Stolzenberg-Solomon R, Pietinen P, et al. Dietary factors of one-carbon metabolism and prostate cancer risk. Am J Clin Nutr 2006;84:929-935 (Pubitemid 44715677)
14. Johansson M, Appleby PN, Allen NE, et al. Circulating concentrations of folate and vitamin B12 in relation to prostate cancer risk: results from the European prospective investigation into cancer and nutrition study. Cancer Epidemiol Biomarkers Prev 2008;17:279-285 (Pubitemid 351272776)
15. Lu QY, Hung JC, Heber D, et al. Inverse associations between plasma lycopene and other carotenoids and prostate cancer. Cancer Epidemiol Biomarkers Prev 2001;10:749-756 (Pubitemid 32695154)
16. McCann SE, Ambrosone CB, Moysich KB, et al. Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York. Nutr Cancer 2005;53:33-41.
17. Figueiredo JC, Grau MV, Haile RW, et al. Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Natl Cancer Inst 2009;101:432-435
18. Rossi E, Hung J, Beilby JP, et al. Folate levels and cancer morbidity and mortality: prospective cohort study from Busselton, Western Australia. Ann Epidemiol 2006;16:206-212 (Pubitemid 43259540)
19. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188
20. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634 (Pubitemid 27387172)
21. Kimura F, Franke KH, Steinhoff C, et al. Methyl group metabolism gene polymorphisms and susceptibility to prostatic carcinoma. Prostate 2000;45:225-231 (Pubitemid 30823398)
22. Heijmans BT, Boer JM, Suchiman HE, et al. A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer. Cancer Res 2003;63:1249-1253 (Pubitemid 36348702)
23. Singal R, Ferdinand L, Das PM, Reis IM, Schlesselman JJ. Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk. Int J Oncol 2004;25:1465-1471
24. Van Guelpen BR, Wiren SM, Bergh AR, et al. Polymorphisms of methylenetetrahydrofolate reductase and the risk of prostate cancer: a nested case-control study. Eur J Cancer Prev 2006;15:46-50. (Pubitemid 43048742)
25. Johansson M, Van GB, Hultdin J, et al. The MTHFR 677C -> T polymorphism and risk of prostate cancer: results from the CAPS study. Cancer Causes Control 2007;18:1169-1174
26. Reljic A, Simundic AM, Topic E, et al. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study. Clin Biochem 2007;40:981-985 (Pubitemid 47301797)
27. Marchal C, Redondo M, Reyes-Engel A, et al. Association between polymorphisms of folate-metabolizing enzymes and risk of prostate cancer. Eur J Surg Oncol 2008;34:805-810 (Pubitemid 351818235)
28. Stevens VL, Rodriguez C, Sun J, et al. No association of single nucleotide polymorphisms in one-carbon metabolism genes with prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2008;17:3612-3614
29. Cicek MS, Nock NL, Li L, et al. Relationship between methylenetetrahydrofolate reductase C677T and A1298C genotypes and haplotypes and prostate cancer risk and aggressiveness. Cancer Epidemiol Biomarkers Prev 2004;13:1331-1336 (Pubitemid 39071557)
30. Amundadottir LT, Sulem P, Gudmundsson J, et al. A common variant associated with prostate cancer in European and African populations. Nat Genet 2006;38:652-658 (Pubitemid 43927306)
31. Yeager M, Orr N, Hayes RB, et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007;39:645-649 (Pubitemid 46676108)
32. Murabito JM, Rosenberg CL, Finger D, et al. A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study. BMC Med Genet 2007;8 Suppl 1:S6. (Pubitemid 351958754)
33. Eeles RA, Kote-Jarai Z, Giles GG, et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 2008;40:316-321 (Pubitemid 351311772)
34. Hazra A, Kraft P, Selhub J, et al. Common variants of FUT2 are associated with plasma vitamin B12 levels. Nat Genet 2008;40:1160-1162
35. von Castel-Dunwoody KM, Kauwell GP, Shelnutt KP, et al. Transcobalamin 776C->G polymorphism negatively affects vitamin B-12 metabolism. Am J Clin Nutr 2005;81:1436-1441
36. Banerjee RV, Matthews RG. Cobalamin-dependent methionine synthase. FASEB J 1990;4:1450-1459
37. Goulding CW, Postigo D, Matthews RG. Cobalamin-dependent methionine synthase is a modular protein with distinct regions for binding homocysteine, methyltetrahydrofolate, cobalamin, and adenosylmethionine. Biochemistry 1997;36:8082-8091 (Pubitemid 27284185)
38. Matthews RG, Sheppard C, Goulding C. Methylenetetrahydrofolate reductase and methionine synthase: biochemistry and molecular biology. Eur J Pediatr 1998;157 Suppl 2:S54-9. (Pubitemid 128684218)
39. Chen J, Stampfer MJ, Ma J, et al. Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk ofmyocardial infarction. Atherosclerosis 2001;154:667-672 (Pubitemid 32232164)
40. Fredriksen A, Meyer K, Ueland PM, et al. Large-scale population-based metabolic phenotyping of thirteen genetic polymorphisms related to one-carbon metabolism. Hum Mutat 2007;28:856-865 (Pubitemid 47579935)
41. Harmon DL, Shields DC, Woodside JV, et al. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol 1999;17:298-309.
42. Tsai MY, Bignell M, Yang F, et al. Polygenic influence on plasma homocysteine: association of two prevalent mutations, the 844ins68 of cystathionine β-synthase and A(2756)G of methionine synthase, with lowered plasma homocysteine levels. Atherosclerosis 2000;149:131-137 (Pubitemid 30125981)
43. Yates Z, Lucock M. Interaction between common folate polymorphisms and B-vitamin nutritional status modulates homocysteine and risk for a thrombotic event. Mol Genet Metab 2003;79:201-213 (Pubitemid 36809048)
44. Brunaud L, Alberto JM, Ayav A, et al. Vitamin B12 is a strong determinant of low methionine synthase activity and DNA hypomethylation in gastrectomized rats. Digestion 2003;68:133-140 (Pubitemid 38056715)
45. Ma J, Stampfer MJ, Christensen B, et al. A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 1999;8:825-829 (Pubitemid 29445020)
46. Yamaji T, Iwasaki M, Sasazuki S, et al. Methionine synthase A2756G polymorphism interacts with alcohol and folate intake to influence the risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2009;18:267-274
47. Ulvik A, Vollset SE, Hansen S, et al. Colorectal cancer and the methylenetetrahydrofolate reductase 677C -> T and methionine synthase 2756A -> G polymorphisms: a study of 2,168 case-control pairs from the JANUS cohort. Cancer Epidemiol Biomarkers Prev 2004;13:2175-2180 (Pubitemid 40054314)
48. Lissowska J, Gaudet MM, Brinton LA, et al. Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses. Int J Cancer 2007;120:2696-2703 (Pubitemid 46651293)
49. Gemmati D, Ongaro A, Scapoli GL, et al. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults. Cancer Epidemiol Biomarkers Prev 2004;13:787-794 (Pubitemid 38737868)
50. Lincz LF, Scorgie FE, Kerridge I, et al. Methionine synthase genetic polymorphism MS A2756G alters susceptibility to follicular but not diffuse large B-cell non-Hodgkin's lymphoma or multiple myeloma. Br J Haematol 2003;120:1051-1054 (Pubitemid 36411565)
51. Lima CS, Ortega MM, Ozelo MC, et al. Polymorphisms of methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), methionine synthase reductase (MTRR), and thymidylate synthase (TYMS) in multiple myeloma risk. Leuk Res 2008;32:401-405
52. Matsuo K, Suzuki R, Hamajima N, et al. Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma. Blood 2001;97:3205-3209
53. Skibola CF, Forrest MS, Coppede F, et al. Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood 2004;104:2155-2162 (Pubitemid 39297871)
54. Koushik A, Kraft P, Fuchs CS, et al. Nonsynonymous polymorphisms in genes in the one-carbon metabolism pathway and associations with colorectal cancer. Cancer Epidemiol Biomarkers Prev 2006;15:2408-2417 (Pubitemid 46048297)
55. Goode EL, Potter JD, Bigler J, Ulrich CM. Methionine synthase D919G polymorphism, folate metabolism, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2004;13:157-162 (Pubitemid 38116635)
56. Le Marchand L, Donlon T, Hankin JH, et al. B-vitamin intake, metabolic genes, and colorectal cancer risk (United States). Cancer Causes Control 2002;13:239-248 (Pubitemid 34438233)
57. Shi Q, Zhang Z, Li G, et al. Polymorphisms of methionine synthase and methionine synthase reductase and risk of lung cancer: a case-control analysis. Pharmacogenet Genomics 2005;15:547-555 (Pubitemid 41044240)
58. Skibola CF, Smith MT, Hubbard A, et al. Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood 2002;99:3786-3791 (Pubitemid 34534552)
59. Heil SG, Van der Put NM, Waas ET, et al. Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects? Mol Genet Metab 2001;73:164-172
60. Chen J, Kyte C, Valcin M, et al. Polymorphisms in the one-carbon metabolic pathway, plasma folate levels and colorectal cancer in a prospective study. Int J Cancer 2004;110:617-620 (Pubitemid 38658029)
61. Hishida A, Matsuo K, Hamajima N, et al. Associations between polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and susceptibility to malignant lymphoma. Haematologica 2003;88:159-166 (Pubitemid 37101493)
62. Moore LE, Malats N, Rothman N, et al. Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer. Int J Cancer 2007;120:2452-2458 (Pubitemid 46642134)
63. Wang L, Lu J, An J, et al. Polymorphisms of cytosolic serine hydroxymethyltransferase and risk of lung cancer: a case-control analysis. Lung Cancer 2007;57:143-151
64. Kelemen LE, Sellers TA, Schildkraut JM, et al. Genetic variation in the one-carbon transfer pathway and ovarian cancer risk. Cancer Res 2008;68:2498-2506